Panacea Biotec has received 2 Demand Orders dated 28.09.2026, from the Office of the Assistant Commissioner of Income Tax, Delhi…
Panacea Biotec (PANACEABIO) said it has received 2 Demand Orders dated 28.09.2026, from the Office of the Assistant Commissioner of Income Tax, Delhi imposing penalty on account. The company is valued at about ₹2,257 crore.
What happened
In a filing with the BSE on 29 September 2026 at 05:57 PM, Panacea Biotec (PANACEABIO) said that it has received 2 Demand Orders dated 28.09.2026, from the Office of the Assistant Commissioner of Income Tax, Delhi imposing penalty on account.
Company snapshot
Panacea Biotec is a small-cap company, with a market value of about ₹2,257 crore.
The stock last traded at ₹368.5, against a 52-week range of ₹292.4–₹647 (43.0% below the high).
Before this filing the shares had moved −6.8% over the month and −32.1% over three months. Average daily turnover over the last 20 sessions was about ₹3.91 crore.
Promoters held 72.48% at the end of Q1 FY27. Foreign institutions owned 2.31% and domestic institutions 2.25%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 167 | 4.1 | 0.66 |
| Q2 FY26 | 141 | -13.9 | -2.27 |
| Q3 FY26 | 165 | 4 | 0.65 |
| Q4 FY26 | 167 | 0.5 | 0.08 |
| Q1 FY27 | 200 | 2.3 | 0.38 |
What history shows
BCEIE's records show 2 previous regulatory filings from the company since May 2026.
Market-wide, 5,432 regulatory filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.